Streamlining Psychiatry Olive AI Replacement for Behavioral Health Prior Authorizations

Navigating the Transition: Klivira's Approach to Olive AI Replacement

Migrating from a prior authorization solution requires careful planning to avoid service disruptions and revenue cycle impacts. Klivira's implementation teams are experienced in integrating with diverse EMR environments, providing a structured pathway for organizations seeking a psychiatry Olive AI replacement. Our platform is built to handle the nuances of behavioral health, ensuring a smooth transition for your prior authorization operations.

Key Prior Authorization Triggers in Psychiatry

• **Inpatient, PHP, IOP, and Residential Admissions:** Requiring admission notifications and concurrent review based on criteria like ASAM or InterQual/MCG behavioral health guidelines.
• **Specialty Psychiatric Medications:** Including long-acting injectable antipsychotics (e.g., paliperidone palmitate), esketamine (Spravato), brexanolone (Zulresso), zuranolone (Zurzuvae), and tardive dyskinesia drugs (e.g., valbenazine).
• **Transcranial Magnetic Stimulation (TMS) and Electroconvulsive Therapy (ECT):** Often requiring documentation of failed medication trials and treatment-resistant indications.
• **Esketamine/Ketamine Clinics:** Payer policies vary, with esketamine having FDA label-specific and REMS-restricted prior authorization paths.
• **Stimulants (Controlled Substances):** Managed with specific documentation and quantity limits.

Maintaining Clinical Integrity: Documentation for Psychiatric PA

Psychiatric prior authorizations are heavily reliant on specific clinical documentation. Klivira's platform is configured to guide users through the capture of necessary data points, aligning with frameworks such as DSM-5-TR, APA Practice Guidelines, and ASAM Criteria for SUD. This includes severity scales (PHQ-9, GAD-7), safety risk assessments, and detailed prior-level-of-care trials for intensive services.

Klivira's Differentiated Approach for Psychiatry PA Automation

Klivira addresses the unique workflow constraints of mental healthcare, including time-sensitive admission decisions and continuous concurrent review for inpatient and residential stays. Our platform incorporates ASAM-criteria-aware logic for level-of-care determinations, automates TMS step-therapy documentation, and flags potential parity issues where payer criteria may appear more restrictive than comparable medical-surgical benefits, a critical consideration for compliance teams.

EMR and Payer Integration Points for Seamless Migration

• **EMR Integration:** Bi-directional data exchange via SMART on FHIR, enabling seamless transfer of patient demographics, diagnoses, and clinical notes for PA submission.
• **Payer Connectivity:** Supports X12 278 transactions, ePA portals, and NCPDP SCRIPT for pharmacy benefits, ensuring comprehensive coverage across diverse payer channels.
• **Clinical Templates:** Pre-built templates for common psychiatric procedures and medications, facilitating efficient data extraction and submission.
• **Order Management:** Integrates with EMR order types for medications, procedures, and admissions, triggering PA workflows automatically.
• **Status Updates:** Real-time updates on authorization status pushed back to the EMR, keeping clinicians and PA coordinators informed.

Mitigating Denials and Ensuring Parity in Mental Healthcare

Common denial reasons in psychiatry, such as ASAM level mismatch, step therapy for TMS or specialty injectables, and concurrent review denials, are directly addressed by Klivira's intelligent workflow. By aligning submissions with payer-specific criteria and leveraging our policy engine for parity-act flag-when-restrictive analysis, we help reduce denials and improve authorization success rates, supporting compliance with MHPAEA.